Wondering what racing a Porsche has in common with running a successful biotech company?
Event Details
The October Bay Area Lifescience meeting will feature Dr. John (Chip) Scarlett, CEO of Geron Corporation, who will discuss what racing and running a biotech company have in common.
$7.00 donation requested at door to cover refreshments
Program
6:00 PM-8:00 PM: Refreshments and Speaker
Speaker Profiles
Chip Scarlett (Speaker)
CEO, Geron Corporation
http://www.geron.com
Speaker Biography:
Chip Scarlett has a wealth of experience founding, operating and selling companies in the biotechnology industry. A 63 y.o. physician-scientist and entrepreneur, Chip is currently CEO and President of Geron Corporation, which is a publicly-traded biotechnology company in Menlo Park (NASDAQ: GERN). Prior to joining Geron, Chip was the President and Chief Executive Officer of Proteolix, a private biotechnology company in South San Francisco, CA, which he merged in October 2009 with Onyx Pharmaceuticals, and a founder and Chief Executive Officer of Tercica, a publicly-traded biotechnology company (NASDAQ: TRCA), which he led from the Series A financing, through the IPO and then through a merger with Ipsen SA in 2008. Chip was also the founder and CEO of Sensus Drug Development Corporation, which he led through its sale to Pharmacia in 2001, and co-founded Covance Biotechnology Services, Inc. (CBSI), a 450-person contract biologics manufacturing and process development business which was sold to Akzo Nobel's Diosynth Division in 2001. Prior to Sensus and CBSI, Chip was the head of clinical development at Novo Nordisk A/S, the Vice President of Greenwich Pharmaceuticals, and the Director of Medical Research and Development at McNeil Pharmaceuticals, a member of the Johnson & Johnson Family of Companies. Chip received his MD degree from the University of Chicago Pritzker School of Medicine and his BA degree in chemistry from Earlham College. He subsequently trained in Internal Medicine at the Hospital of the University of Pennsylvania and in Endocrinology and Metabolism at the University of Colorado, where he was also a member of the faculty at both CU and the Veterans Administration.